10-Q: Atomera Reports Q1 2026 Results, Secures Funding

Atomera Incorporated reported its first quarter 2026 financial results, highlighting increased revenue and successful capital raises to support ongoing operations and technology development.

Summary

• Atomera Incorporated reported its financial results for the first quarter ended March 31, 2026.
• The company generated $11,000 in revenue, an increase from $4,000 in the same period of 2025.
• Cost of revenue was $126,000 for Q1 2026, compared to $0 in Q1 2025.
• Operating expenses totaled $6.2 million for Q1 2026, up from $5.5 million in Q1 2025.
• Research and development expenses were $3.5 million, general and administrative expenses were $2.3 million, and selling and marketing expenses were $419,000.
• The net loss for the quarter was $6.1 million, compared to a net loss of $5.2 million in Q1 2025.
• As of March 31, 2026, the company had cash, cash equivalents, and short-term investments of approximately $41.1 million.
• The company completed a registered direct offering of 5,000,000 shares of common stock at $5.00 per share, raising approximately $23.6 million in net proceeds.
• Atomera also sold approximately 1.3 million shares of common stock through its at-the-market offering, generating approximately $3.1 million in net proceeds.
• The company believes it has sufficient capital to fund its operations for at least the next 24 months.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to increased net loss and operating expenses, despite successful capital raises and a slight revenue increase. The company remains in an early stage with significant operational losses.

Positives

• Revenue increased to $11,000 in Q1 2026 from $4,000 in Q1 2025.
• Successful completion of a registered direct offering, raising approximately $23.6 million in net proceeds.
• Continued sales through the at-the-market offering, generating approximately $3.1 million in net proceeds.
• Sufficient capital to fund operations for at least the next 24 months.
• Positive cash flow from financing activities of $26.5 million in Q1 2026.

Negatives

• Net loss increased to $6.1 million in Q1 2026 from $5.2 million in Q1 2025.
• Operating expenses increased to $6.2 million in Q1 2026 from $5.5 million in Q1 2025.
• Cost of revenue increased significantly to $126,000 in Q1 2026 from $0 in Q1 2025.
• Net cash used in operating activities was $4.6 million in Q1 2026.

Risks

• The company is an early-stage company with limited revenue-generating activities and recurring operating losses, subject to risks inherent in new businesses not generating positive cash flow.
• Future capital requirements and the adequacy of available funds depend on the ability to commercialize technology, market developments, and potential collaborations or acquisitions.
• If sufficient revenue is not generated, the company may need to raise more capital through various financing sources or curtail R&D initiatives and reduce costs.
• The company's technology is subject to competition from other semiconductor technologies and market developments.
• The success of the business depends on entering into commercial license agreements and generating license revenues and royalties.

Future Outlook

The company believes its available working capital is sufficient to fund its presently forecasted working capital requirements for at least the next 24 months. However, future capital requirements will depend on commercialization success, market developments, and potential collaborations. If sufficient revenue is not generated, additional capital may be needed, potentially requiring curtailment of R&D or cost reductions.

Management Comments

• "Based on the funds it has available as of the date of the filing of this report, the Company believes that it has sufficient capital to fund its current business plans and obligations over, at least, 24 months from the date that these financial statements have been issued."
• "The Company's future capital requirements and the adequacy of its available funds will depend on many factors, including the Company's ability to successfully commercialize its technology, competing technological and market developments, and the need to enter into collaborations with other companies or acquire technologies to enhance or complement its current offerings."
• "If we are not able to generate sufficient revenue from license fees and royalties in a timeframe that satisfies our cash needs, we will need to raise more capital."

Industry Context

StockSavvy.ai notes that Atomera operates in the highly competitive and capital-intensive semiconductor industry, where technological innovation and efficient manufacturing are paramount. The company's focus on a proprietary performance enhancement technology (MST) aims to address key industry challenges like miniaturization, speed, reliability, and power efficiency, which are critical for next-generation integrated circuits.

Comparison to Industry Standards

• Atomera's revenue of $11,000 for the quarter is significantly lower than established semiconductor manufacturers, reflecting its early-stage, technology-licensing business model.
• The company's net loss of $6.1 million is typical for early-stage technology companies investing heavily in R&D, aiming for future market penetration.
• The capital raised through equity offerings ($23.6 million direct offering and $3.1 million ATM) is a common strategy for semiconductor startups to fund R&D and commercialization efforts, aligning with industry practices for companies not yet generating substantial revenue.
• The company's stated goal of enabling transistors to be made smaller, with increased speed, reliability, and power efficiency aligns with the industry's continuous drive for Moore's Law advancements and improved energy efficiency in electronic devices.

Legal Proceedings

• The Company is not party to any material litigation as of March 31, 2026, or through the date these financial statements have been issued.

Stakeholder Impact

• Shareholders: Dilution from recent equity offerings, but also potential for future value creation if MST technology is successfully commercialized. The company's ability to secure future funding impacts shareholder value.
• Employees: Continued investment in R&D and potential for growth may lead to job security and opportunities. Stock-based compensation remains a significant expense.
• Customers/Partners: Access to Atomera's MST technology for improved semiconductor performance. The company's financial stability is crucial for long-term partnerships.
• Creditors: The company's current liquidity and cash burn rate are important considerations for any potential debt financing.

Next Steps

• Continue to commercialize MST technology and enter into commercial license agreements.
• Generate license revenues and ongoing royalties.
• Utilize capital raised to fund business plans and obligations.
• Monitor future capital requirements and explore financing sources if needed.
• Potentially curtail R&D initiatives and reduce costs if additional capital cannot be secured.

Key Dates

Recommendation

Atomera's Q1 2026 results show a worsening net loss and increased operating expenses, despite successful capital raises. While the company has secured sufficient funding for the next 24 months and revenue saw a modest increase, the path to profitability remains long and uncertain. The technology's commercialization success is still a key factor. Therefore, a 'hold' recommendation is appropriate, awaiting clearer signs of revenue growth and a reduction in losses.

Keywords

Atomera, 10-Q, Semiconductor, MST technology, Financial Results, Q1 2026, Capital Raise, Stock Options, Revenue, Net Loss